Regeneron Pharmaceuticals revenue increased from $6.7 billion in 2018 to $7.9 billion in 2019, a 17.2% increase.

Annual Revenue ($)

Regeneron Pharmaceuticals revenue was $7.86 b in FY, 2019 which is a 17.2% year over year increase from the previous period.

Quarterly Revenue ($)

FY, 2016FY, 2017FY, 2018FY, 2019
Revenue$4.86 b$5.87 b$6.71 b$7.86 b
Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020
Revenue$1.32 b$1.47 b$1.50 b$1.51 b$1.61 b$1.66 b$1.71 b$1.93 b$2.05 b$1.83 b

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Regeneron Pharmaceuticals revenue breakdown by business segment: 28.9% from Sanofi and Bayer Collaboration, 68.7% from Product Sales and 2.5% from Other

FY, 2019FY, 2018FY, 2017FY, 2016
Sanofi and Bayer Collaboration2.62 b2.19 b1.82 b1.40 b
Product Sales4.83 b4.11 b3.72 b3.34 b
Other413.40 m416.80 m338.52 m119.10 m

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.